Effect of increased water intake on plasma copeptin in healthy adults

European Journal of Nutrition

Volumn 57, Issue 5, 2018, Pages 1883-1890

  Lemetais, Guillaume ^a   Melander, Olle ^b,c   Vecchio, Mariacristina ^a   Bottin, Jeanne H ^a   Enhörning, Sofia ^b,c   Perrier, Erica T ^a  

^a Danone Research   (France)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Copeptin; Fluid intake; Hydration; Urine osmolality; Water intake

Indexed keywords

COPEPTIN; DRINKING WATER; GLYCOPEPTIDE;

ADULT; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; CREATININE URINE LEVEL; DIETARY REFERENCE INTAKE; FEMALE; FLUID BALANCE; FLUID INTAKE; FOLLOW UP; HUMAN; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PLASMA OSMOLALITY; PROSPECTIVE STUDY; RELATIVE DENSITY; RENAL SYSTEM PARAMETERS; SUGAR-SWEETENED BEVERAGE; URINE OSMOLALITY; URINE SPECIFIC GRAVITY; WATER METABOLISM; YOUNG ADULT; BLOOD; DRINKING; FRANCE; OSMOLARITY; URINALYSIS; URINE;

ADULT; DRINKING; FEMALE; FRANCE; GLYCOPEPTIDES; HUMANS; MALE; OSMOLAR CONCENTRATION; PROSPECTIVE STUDIES; URINALYSIS;

EID: 85020065289     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-017-1471-6     Document Type: Article

References (31)

1. Abbasi A, Corpeleijn E, Meijer E, Postmus D, Gansevoort RT, Gans ROB, Struck J, Hillege HL, Stolk RP, Navis G, Bakker SJL (2012) Sex differences in the association between plasma copeptin and incident type 2 diabetes: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study. Diabetologia 55(7):1963–1970
2. Enhorning S, Wang TJ, Nilsson PM, Almgren P, Hedblad B, Berglund G, Struck J, Morgenthaler NG, Bergmann A, Lindholm E, Groop L, Lyssenko V, Orho-Melander M, Newton-Cheh C, Melander O (2010) Plasma copeptin and the risk of diabetes mellitus. Circulation 121(19):2102–2108
3. Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N (2015) Copeptin, insulin resistance, and risk of incident diabetes in older men. J Clin Endocrinol Metab 100(9):3332–3339
4. Enhorning S, Struck J, Wirfalt E, Hedblad B, Morgenthaler NG, Melander O (2011) Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 96(7):1065–1072
5. Saleem U, Khaleghi M, Morgenthaler NG, Bergmann A, Struck J, Mosley TH Jr, Kullo IJ (2009) Plasma carboxy-terminal provasopressin (copeptin): a novel marker of insulin resistance and metabolic syndrome. J Clin Endocrinol Metab 94(7):2558–2564
6. Boertien WE, Meijer E, Zittema D, van Dijk MA, Rabelink TJ, Breuning MH, Struck J, Bakker SJL, Peters DJM, de Jong PE, Gansevoort RT (2012) Copeptin, a surrogate marker for vasopressin, is associated with kidney function decline in subjects with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant 27(11):4131–4137
7. Meijer E, Bakker SJL, de Jong PE, van der Heide JJH, van Son WJ, Struck J, Lems SPM, Gansevoort RT (2009) Copeptin, a surrogate marker of vasopressin, is associated with accelerated renal function decline in renal transplant recipients. Transplantation 88(4):561–567
8. Roussel R, Fezeu L, Marre M, Velho G, Fumeron F, Jungers P, Lantieri O, Balkau B, Bouby N, Bankir L (2014) Comparison between copeptin and vasopressin in a population from the community and in people with chronic kidney disease. J Clin Endocrinol Metab 99(12):4656–4663
9. Roussel R, Matallah N, Bouby N, El Boustany R, Potier L, Fumeron F, Mohammedi K, Balkau B, Marre M, Bankir L (2015) Plasma copeptin and decline in renal function in a cohort from the community: the prospective DESIR study. Am J Nephrol 42(2):107–114
10. Enhorning S, Hedblad B, Nilsson PM, Engström G, Melander O (2015) Copeptin is an independent predictor of diabetic heart disease and death. Am Heart J 169(4):549–556
11. Tasevska I, Enhorning S, Persson M, Nilsson PM, Melander O (2015) Copeptin predicts coronary artery disease cardiovascular and total mortality. Heart 102(2):127–132
12. Yalta K, Yalta T, Sivri N, Yetkin E (2013) Copeptin and cardiovascular disease: a review of a novel neurohormone. Int J Cardiol 167(5):1750–1759
13. Verbalis JG (2003) Disorders of body water homeostasis. Best Pract Res Cl En 17(4):471–503
14. Knepper MA, Kwon TH, Nielsen S (2015) Molecular physiology of water balance. N Engl J Med 372(14):1349–1358
15. Robertson GL, Shelton RL, Athar S (1976) The osmoregulation of vasopressin. Kidney Int 10(1):25–37
16. Perrier ET, Armstrong LE, Daudon M, Kavouras S, Lafontan M, Lang F, Péronnet F, Stookey JD, Tack I, Klein A (2014) From state to process: defining hydration. Obes Facts 7(Suppl. 2):6–12
17. Armstrong LE, Johnson EC, McKenzie AL, Munoz CX (2013) Interpreting common hydration biomarkers on the basis of solute and water excretion. Eur J Clin Nutr 67(3):249–253
18. Robertson GL, Mahr EA, Athar S, Sinha T (1973) Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 52(9):2340
19. Perrier ET, Buendia-Jimenez I, Vecchio M, Armstrong LE, Tack I, Klein A (2015) Twenty-four-hour urine osmolality as a physiological index of adequate water intake. Dis Mark. doi:10.1155/2015/231063
20. Fenske W, Stork S, Blechschmidt A, Maier SGK, Morgenthaler NG, Allolio B (2009) Copeptin in the differential diagnosis of hyponatremia. J Clin Endocrinol Metab 94(1):123–129
21. World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310(20):2191
22. Bottin JH, Lemetais G, Poupin M, Jimenez L, Perrier ET (2016) Equivalence of afternoon spot and 24-h urinary hydration biomarkers in free-living healthy adults. Eur J Clin Nutr 70(8):904–907
23. Agostoni CV, Bresson JL, Fairweather-Tait S (2010) Scientific opinion on dietary reference values for water. EFSA J 8(3):1459
24. Ponte B, Pruijm M, Ackermann D, Vuistiner P, Guessous I, Ehret G, Alwan H, Youhanna S, Paccaud F, Mohaupt M, Péchère-Bertschi A, Vogt B, Burnier M, Martin P-Y, Devuyst O, Bochud M (2014) Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study. J Am Soc Nephrol 26(6):1415–1425
25. Perrier E, Sb Vergne, Klein A, Poupin M, Rondeau P, Le Bellego L, Armstrong LE, Lang F, Stookey J, Tack I (2013) Hydration biomarkers in free-living adults with different levels of habitual fluid consumption. Br J Nutr 109(09):1678–1687
26. Armstrong LE, Johnson EC, McKenzie AL, Munoz CX (2015) An empirical method to determine inadequacy of dietary water. Nutrition 32(1):79–82
27. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155(3):839–843
28. Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX (2011) Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 6(11):2634–2641
29. Sontrop JM, Dixon SN, Garg AX, Buendia-Jimenez I, Dohein O, Huang SH, Clark WF (2013) Association between water intake, chronic kidney disease, and cardiovascular disease: a cross-sectional analysis of NHANES data. Am J Nephrol 37(5):434–442
30. Ferreira-Pêgo C, Guelinckx I, Moreno LA, Kavouras SA, Gandy J, Martinez H, Bardosono S, Abdollahi M, Nasseri E, Jarosz A, Babio N, Salas-Salvado J (2015) Total fluid intake and its determinants: cross-sectional surveys among adults in 13 countries worldwide. Eur J Nutr 54(2):35–43
31. Sontrop JM, Huang SH, Garg AX, Moist L, House AA, Gallo K, Clark WF (2015) Effect of increased water intake on plasma copeptin in patients with chronic kidney disease: results from a pilot randomised controlled trial. BMJ Open 5(11):e008634